dr-anthony-s-rebuck-senior-consultant-head-of-strategic-drug-development-asia-quintiles-singapore

COPD in Asia is a gathering storm

  • Singapore
  • |
  • Opinion
  • |
  • By Dr Anthony S Rebuck
  • |
  • 0 Comment

Predictions for the burden and impact of Chronic Obstructive Pulmonary Disease (COPD) have exceeded all expectations. In 1996, the World Health Organization (WHO)... Read more

dhl-global-forwarding-has-launched-dhl-thermonet-a-new-air-freight-product-tailored-to-the-life-sciences-and-healthcare-sector

DHL launches air freight service for bio firms

  • Singapore
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: DHL Global Forwarding, air and ocean freight specialist, has launched DHL Thermonet, a new air freight product tailored to the life sciences and healthcare... Read more

Biotech-310x175_copy

What were the top 20 M&A deals in pharma and biotech sector...

  • China
  • |
  • Analysis
  • |
  • By Amrita Tejasvi
  • |
  • 0 Comment

A majority of life science firms are standing on the edge of the patent cliff and their drug pipelines are experiencing acute scarcity. This is making them seek... Read more

Biotech-310x175_copy

What were the top 20 global M&A transactions of 2012?

  • Singapore
  • |
  • Analysis
  • |
  • By Amrita Tejasvi
  • |
  • 0 Comment

A majority of life science firms are standing on the edge of the patent cliff and their drug pipelines are experiencing acute scarcity. This is making them seek... Read more

apac-witnesses-mergers-acquisitions-m-a-galore-during-q1-2013

What are the key mergers & acquisitions of Q1 2013?

  • India
  • |
  • Analysis
  • |
  • By Amrita Tejasvi
  • |
  • 0 Comment

Most pharmaceutical companies are sitting on the patent cliff and their drug pipelines are facing severe exhaustion. The big players of the industry are thus looking... Read more

m-a-analysis-biospectrum-asia-top-20-survey

Why did mergers & acquisitions plunge in APAC?

  • China
  • |
  • Analysis
  • |
  • By Amrita Tejasvi
  • |
  • 0 Comment

The global bioscience industry, in 2012, reported 450 mergers and acquisitions (M&A) transactions valued at $67 billion, which is about 10 percent lower than the... Read more

vela-diagnostics-pcr-based-research-use-only-will-identify-new-strain-of-bird-flu-h7n9-and-coronavirus-hcov-emc

Vela develops genetic tests for H7N9 bird flu

  • Singapore
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Vela Diagnostics has launched PCR-based Research-Use-Only (RUO) tests for the identification of genetic targets specific to a new strain of bird flu (H7N9),... Read more

bayer-healthcare-s-gideon-global-investigation-of-therapeutic-decisions-in-hepatocellular-carcinoma-and-of-its-treatment-with-sorafenib-study-progressed-with-positive-data-in-phase-iii-trial

Bayer progresses on APAC hepatocellular carcinoma trial...

  • Singapore
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: GIDEON (Global Investigation of therapeutic Decisions in hepatocellular carcinoma and of its treatment with sorafenib) study by Bayer HealthCare, a global... Read more

frost-and-sullivan-report-asia-pacific-hospital-market-will-reach-usd1085

F&S: APAC hospital market touches $378 bn

  • China
  • |
  • Analysis
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: According to a Frost and Sullivan report, Asia Pacific hospital market earned revenues of more than $377.90 billion in 2012 and estimates this to reach... Read more

Previous 1 3 4 5 6 7

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X